Abstract Representative, reproducible, and high-throughput models of human cells and tissues are critical for a meaningful evaluation of host-pathogen interactions and are an essential component of the research developmental pipeline. The most informative infection models-animals, organ explants, and human trials-are not suited for extensive evaluation of pathogenesis mechanisms and screening of candidate drugs. At the other extreme, more cost-effective and accessible infection models such as conventional cell culture and static coculture may not capture physiological and three-dimensional (3-D) aspects of tissue biology that are important in assessing pathogenesis, effectiveness, and cytotoxicity of therapeutics. Our lab has used innovative bioengineering technology to establish biologically meaningful 3-D models of human tissues that recapitulate many aspects of the differentiated structure and function of the parental tissue in vivo, and we have applied these models to study infectious disease. We have established a variety of different 3-D models that are currently being used in infection studies-including small intestine, colon, lung, placenta, bladder, periodontal ligament, and neuronal models. Published work from our lab has shown that our 3-D models respond to infection with bacterial and viral pathogens in ways that reflect the infection process in vivo. By virtue of their physiological relevance, 3-D cell cultures may also hold significant potential as models to provide insight into the neuropathogenesis of HIV infection. Furthermore, the experimental flexibility, reproducibility, cost efficiency, and high-throughput platform afforded by these 3-D models may have important implications for the design and development of drugs with which to effectively treat neurological complications of HIV infection.
Introduction
The more closely the phenotype of a cell culture model resembles its parental tissue, the greater will be the relevance of that model to the infection process in vivo. Thus, a more complete understanding of the mechanisms of human infectious disease will depend upon the development of physiologically relevant (i.e., organotypic) models of human cell cultures that can be used to identify and characterize host and microbial products important for infection. Such models also have exciting potential for the discovery and development of novel therapeutics.
Much of our knowledge of how microbial pathogens cause infection is based on studying experimental infections of standard monolayers grown as flat two-dimensional (2-D) cultures on impermeable surfaces of plastic or glass. Whereas these models continue to contribute to our understanding of infectious diseases, they are greatly limited in the extent to which they model the complexity of an intact three-dimensional (3-D) tissue. In particular, this method of culture prevents the cells from establishing the 3-D architecture that is critical for the differentiated structure and function of parental tissues in vivo (Abbott 2003; O'Brien et al. 2002; Schmeichel and Bissell 2003; Zhang 2004 ). In addition, cells grown as standard 2-D monolayers are also unable to respond to chemical and molecular gradients in three dimensions (at apical, basal, and lateral cell surfaces), resulting in many departures from in vivo behavior (Zhang 2004) .
There are a variety of methods that have been used to enhance the differentiation of cultured cells, including permeable inserts, transplanted human cells grown as xenografts in animals, and explanted human biopsies. Whereas these advanced in vitro models have provided important insights into microbial pathogenesis, they suffer from limitations such as short lifetimes, laborious set-up, experimental variability, availability, and limited numbers of cells.
Use of the RWV bioreactor to engineer biologically meaningful 3-D cell cultures
Optimally, cell culture model design should mimic both the 3-D organization and differentiated function of an organ, while allowing for experimental analysis in a high throughput platform.
Originally designed by NASA engineers, the RWV is an optimized suspension culture technology for growing 3-D cells that maintain many of the specialized features of in vivo tissues Unsworth and Lelkes 1998) . The RWV bioreactor is based on a rotating cylinder completely filled with culture medium in which the sedimentation of cells within the vessel is offset by the rotating fluid, creating a constant fall of cells through the culture medium (Fig. 1) . Oxygen is provided to cells through a hydrophobic membrane at the back of the bioreactor. These conditions maintain cells in suspension under levels of low, physiologically relevant fluid shear, enabling them to (1) attach to one another and form aggregates based on natural cellular affinities, (2) grow in three dimensions, (3) differentiate, and (4) form the fragile connections that are required for complex tissue-like 3-D structures Unsworth and Lelkes 1998) (Fig. 1) .
Applying 3-D cell cultures to study infectious disease
Cell culture in the RWV is easy to perform. Cells are first grown as monolayers in tissue culture flasks. At the appropriate density, cells are removed from the flask, resuspended in medium, and incubated with porous collagen-coated microcarrier beads for attachment ( Fig. 1 ) (microcarriers can be coated with any extracellular matrix/ ECM molecule of choice). The cell-bead complexes are then introduced into the RWV and rotation is initiated. Three-dimensional cells cultured on the surface of porous microcarrier beads are able to sense and respond to chemical and molecular gradients like the parental tissue in vivo (i.e., at apical, lateral, and basal cell surfaces). The medium is changed as necessary and vessel rotation speed is increased as cultures grow to maintain cells in suspension. The 3-D cell cultures are then removed from the bioreactor and distributed evenly in multiwell plates or other convenient formats for testing. Three-dimensional cells are amenable to a wide range of experimental manipulations commonly used to study host-pathogen interactions, including adherence, invasion and intracellular survival, genomic and proteomic expression profiling, immunologic activation, analysis of secreted effectors, signal transduction, and microscopic imaging (Carterson et al. 2005; Lamarca et al. 2005; Nickerson et al. 2001; Höner zu Bentrup et al. 2006; Straub, et al., Accepted. Long et al. 1999; Smith et al. 2006; Duray et al. 2005 ). In addition, 3-D cultures can be removed from the bead with various treatments for use in studies that require homogeneous cell suspensions, like flow cytometry.
Studies from our team and others have shown that a variety of different 3-D cell cultures more closely resemble the physiology of their parental tissues in vivo compared to the same cells grown as monolayers, and respond to infection with microbial pathogens in ways that reflect the natural infection process (Carterson et al. 2005; Lamarca et al. 2005; Nickerson et al. 2001; Höner zu Bentrup et al. 2006; Straub, et al., Accepted. Long et al. 1999; Smith et al. 2006; Duray et al. 2005) . Specifically, we have published the use of 3-D cell culture systems in infection studies with the following pathogens: Salmonella typhimurium (small intestine and colon models) (Nickerson et al. 2001; Höner zu Bentrup et al. 2006) , Pseudomonas aeruginosa (lung model) (Carterson et al. 2005) , and human cytomegalovirus (placental model) (Lamarca et al. 2005) ; and Norwalk virus (Straub, et al., Accepted) . Others have used 3-D cell culture models of other tissue types, including bladder, tonsil, and B cells to study infections with Escherichia coli, Borrelia burgdorferi, and Epstein-Barr virus, respectively (Smith et al. 2006; Duray et al. 2005; Long et al. 1999) . Additional studies are on-going in our lab with other 3-D models and infectious agents, including bacteria, viruses, and parasites -including those that are difficult or not possible to culture using conventional methods. In this regard, we recently reported the first succesful in vitro cell culture infectivity assay for human Norwalk virus using our 3-D small intestinal model (Straub, et al., Accepted) .
We reported the first use of 3-D cell culture models of human intestinal epithelium generated in the RWV to study the enteric pathogen S. typhimurium (Nickerson et al. 2001) (Fig. 2) . Compared to monolayers, 3-D culture of human intestinal cell lines (small intestine and colon) enhanced many characteristics associated with fully differentiated functional intestinal epithelia in vivo, including distinct apical and basolateral polarity, increased expression and better organization of tight junction, extracellular matrix, and brush border proteins, and highly localized expression of mucins (Fig. 3) . All of these important physiological features of in vivo intestinal epithelium were either absent or not expressed or distributed at physiologically relevant levels in monolayer cultures of these same cells (Nickerson et al. 2001; Höner zu Bentrup et al. 2006) . Moreover, our 3-D intestinal cultures in the RWV grew predominantly as unilayers on porous collagen I-coated microcarrier beads, which recapitulates normal intestinal epithelium in vivo, which consists of a single layer of cells (Fig. 4) . This physiologically relevant pattern of growth was not observed for monolayers of the same cells, which grew past confluence and stacked on top of each other. When applied to study aspects of human enteric salmonellosis (using the virulent S. typhimurium strain χ3339), our 3-D intestinal cultures responded in ways that were similar to an in vivo infection, including differences in tissue pathology, adherence, invasion, apoptosis, and cytokine expression (Nickerson et al. 2001; Höner zu Bentrup et al. 2006) . Other published and/or submitted studies with Recently, we described the establishment and characterization of a 3-D model of human lung epithelium and its application to study the pathogenesis of P. aeruginosa (Carterson et al. 2005) . As with our 3-D intestinal models, cultivation of a human lung cell line in the RWV resulted in the formation of 3-D tissue aggregates that displayed important structural and functional characteristics of the differentiated parental tissue, including enhanced and extensive formation of tight junctions, extracellular matrix proteins, and mucus production. These features were not observed in monolayers of the same cells. In response to infection with P. aeruginosa strain PAO1, the 3-D lung cells, but not monolayers, responded in ways that were relevant to the infection in vivo, including differences in bacterial colonization, cellular morphology, and cytokine expression profiles. Collectively, these studies show that the use of the RWV to generate 3-D cultures from a variety of cell types has wide applications in the modeling of infectious disease.
Conclusions
Three-dimensional cell culture has wide applications for infectious disease studies and drug development. Indeed, 3-D cell cultures provide alternative organotypic models that will complement existing experimental systems to study human infectious disease, and are a powerful tool for the commercial development of novel therapeutics. We, along with our collaborators, have generated a variety of 3-D cell cultures from different human tissues that model many aspects of their in vivo parental tissues, and which are being used in infection studies (Carterson et al. 2005; Lamarca et al. 2005; Nickerson et al. 2001; Höner zu Bentrup et al. 2006; Straub et al., Accepted) . These 3-D cell cultures include models of colon, lung, placenta, bladder, periodontal ligament, tonsil, B cell, and more recently, neuronal cultures. By virtue of their physiological relevance, 3-D cell cultures may also hold significant potential as models to provide insight into the neuropathogenesis of HIV infection. For example, observations from preliminary studies show that our 3-D neuronal cultures exhibit morphological and functional characteristics relevant to their parental cells in vivo. Such models may hold important utility for Neuro-AIDS research, including (1) cross-clade assessment of infection in 3-D tissues examining HIV-1 variants, neurotoxic effects, and other host responses; (2) the role of viral proteins and drugs in neurotoxicity; (3) the contribution of drug abuse to HIV-related CNS disease; and (4) the efficacy of candidate drugs. Furthermore, the experimental flexibility, reproducibility, cost efficiency, and high-throughput platform afforded by these 3-D models may have important implications for the design and development of drugs to effectively treat neurological complications of HIV infection.
Beyond our infectious disease applications, 3-D cell cultures have been used in a variety of other biomedical applications such as cancer biology, stem cell research, the study of immune cell interactions, the growth of tissues for transplantation, and the development and testing of novel therapeutics (http://www.synthecon.com).
These 3-D models are simple, high-throughput systems that create very large numbers of cells per experiment, and can be studied by techniques not possible or limited in many other advanced in vitro models. The high fidelity, reproducibility, and cost efficiency of 3-D cell culture offers a powerful screening tool for therapeutics and holds tremendous potential for drug and target validation and discovery. Three-dimensional cell-based models have been effectively used to reexamine molecular pathways previously characterized by conventional culture methodologies and to elucidate novel signaling pathways during normal cellular differentiation and tumor progression (Schmeichel and Bissell 2003) . By analogy, 3-D cell culture holds enormous potential for novel product development for the diagnosis, prevention, and treatment of infectious disease. 
